Albireo Pharma Inc Forecast and Stock Analysis
Technical ALBO stock analysis for April 23, 2019.
Albireo Pharma Inc gained 4.01% in the last trading day, rising from $30.67 to $31.90 The price has been going up and down for this period, and there has been a -8.2% loss for the last 2 weeks. Volume fell in the last day by -8 892 shares, and in total, 20 212 shares bought and sold for approximately $644 763.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Tuesday, 23rd Apr 2019) of the ALBO stock was $31.90. This is 4.01% more than the trading day before Monday, 22nd Apr 2019.
During day the stock fluctuated 7.94% from a day low at $30.28 to a day high of $32.69.
30 day high of the ALBO stock price was $35.30 and low was $27.83.
90 day high was $35.30 and low was $21.80.
52 week high for the Albireo Pharma Inc - $37.95 and low - $19.10.
Albireo Pharma Inc lies in the lower part of a wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $30.84 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 37.43% during the next 3 months and, with 90% probability hold a price between $42.38 and $52.40 at the end of this period.
Albireo Pharma Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $31.99. On a fall, the stock will find some support from the long-term average at approximately $31.66. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Monday April 22, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSI14 is 44 and the stock is currently not being overbought or oversold
Support & Resistance
Albireo Pharma Inc finds support from accumulated volume at $31.00.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $2.40 between high and low, or 7.94%. For the last week the stock has had a daily average volatility of 5.50%.
Our recommended stoploss: $30.40 (-4.70%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ALBO $31.90 ($1.23 4.01%)|
ALBO is up $1.23 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ALBO based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ALBO analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us